Le Lézard

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...

Fran Drescher Says Being Told She Could Never Have Kids After Cancer Was a 'Bitter Pill to Swallow' (Exclusive)

The actress recalls being misdiagnosed by 8 doctors when she had uterine cancer, and after her hysterectomy, embracing her ...

A midwife’s death days after childbirth complications reignites the conversation around Black maternal health

Janell Green Smith was a certified nurse-midwife and doctor of nursing practice in South Carolina. Less than a week after ...
Le Lézard

RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer

Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...
The Scientist

US Office of Research Integrity Reported Just Two Misconduct Cases in 2025

Research misconduct findings dropped sharply in 2025, prompting scrutiny of ORI leadership turnover and staffing cuts.